dup 105 has been researched along with vancomycin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mazzei, T; Mini, E; Novelli, A; Periti, P | 1 |
Brumfitt, W; Hamilton-Miller, JM; Maple, PA | 1 |
Barry, AL | 1 |
3 other study(ies) available for dup 105 and vancomycin
Article | Year |
---|---|
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Glycopeptides; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1989 |
Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Depsipeptides; Disaccharides; Drug Resistance, Microbial; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Peptides, Cyclic; Staphylococcus aureus; Teicoplanin; Temperature; Vancomycin | 1989 |
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Chemical Phenomena; Chemistry; Ciprofloxacin; Erythromycin; Gram-Positive Bacteria; Oxazoles; Oxazolidinones; Vancomycin | 1988 |